updated 2/20/2009 10:36:22 AM ET 2009-02-20T15:36:22

Swiss pharmaceutical company Novartis is launching a new cherry-flavored malaria drug that it says children will be less likely to spit out.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

The child-friendly version of its Coartem malaria pill dissolves in water, as well as breast milk, and tastes like fruit juice.

"If our children accept this new form (of the malaria drug) then it will mark a major step forward," Senegalese Health Minister Safiatou Thiam Sy said on the sidelines of Friday's launch in the West African country.

Though preventable and treatable, malaria remains one of the world's biggest killers, claiming 1 million lives each year. Nine out of 10 of malaria deaths occur in sub-Saharan Africa — and the majority are children. The World Health Organization estimates that every 30 seconds a child dies of malaria in Africa.

Hans Rietveld, director of marketing for Basel, Switzerland-based Novartis' malaria initiative, said that until now, mothers were forced to crush the anti-malarial pill and mix it with sugar in order to trick children into swallowing it.

Even under a cloak of sugar, the pill still tastes bitter, causing many children, especially infants, to spit it out.

Partially funded by the Bill and Melinda Gates Foundation, the children's version of Coartem is being launched in several African countries this week, including Senegal.

It is being provided to participating governments for a subsidized price of 30 cents per treatment course per child — a cost that Sy says is affordable for a majority of Africans.

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments